Benitec Biopharma Inc. (BNTC)
NASDAQ: BNTC · Real-Time Price · USD
9.07
+0.20 (2.25%)
Oct 12, 2026, 4:00 PM EDT - Market closed
Benitec Biopharma Market Cap
Benitec Biopharma has a market cap or net worth of $316.39 million as of October 12, 2026. It is the 18,225th most valuable company in the world and the 3,195th biggest in the United States. Its market cap has decreased by 19.23% in one year.
Market Cap
316.39M
Enterprise Value
137.18M
1-Year Change
-19.23%
Global Rank
Country Rank
#3,195 United States
Category
ChartMarket Cap Chart
Since August 18, 2015, Benitec Biopharma's market cap has increased from $46.20M to $316.39M, an increase of 584.82%. That is a compound annual growth rate of 18.82%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 12, 2026 | 316.39M | -30.63% |
| Dec 31, 2025 | 456.10M | 55.56% |
| Dec 31, 2024 | 293.20M | 3,432.53% |
| Dec 29, 2023 | 8.30M | 72.92% |
| Dec 30, 2022 | 4.80M | -77.57% |
| Dec 31, 2021 | 21.40M | 62.12% |
| Dec 31, 2020 | 13.20M | 100.00% |
| Dec 31, 2019 | 6.60M | -65.80% |
| Dec 31, 2018 | 19.30M | -36.51% |
| Dec 29, 2017 | 30.40M | 171.43% |
| Dec 30, 2016 | 11.20M | -51.93% |
| Dec 31, 2015 | 23.30M | -49.57% |
| Aug 18, 2015 | 46.20M | - |
View and export this data all the way back to 2015. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Artiva Biotherapeutics | 339.30M |
| Indaptus Therapeutics | 334.44M |
| Cabaletta Bio | 327.22M |
| Ocugen | 324.02M |
| EyePoint | 293.12M |
| X4 Pharmaceuticals | 288.52M |
| Fulcrum Therapeutics | 287.64M |
| Nautilus Biotechnology | 286.32M |